ASPG Human Pre-designed siRNA Set A contains three designed siRNAs for ASPG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPH Human Pre-designed siRNA Set A contains three designed siRNAs for ASPH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASPHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPM Human Pre-designed siRNA Set A contains three designed siRNAs for ASPM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPN Human Pre-designed siRNA Set A contains three designed siRNAs for ASPN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPRV1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASPRV1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASPSCR1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASPSCR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASRGL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASRGL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASS1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASTE1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASTE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Asteltoxin is an inhibitor for extracellular vesicles (EV), which exhibits inhibitory effects towards mitochondrial ATP synthase and mTORC1 activation[1].

ASTL Human Pre-designed siRNA Set A contains three designed siRNAs for ASTL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASTN1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASTN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASTN2 Human Pre-designed siRNA Set A contains three designed siRNAs for ASTN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Astrazone pink FG is a pink dye.

ASXL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASXL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASXL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ASXL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASXL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ASXL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ASZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for ASZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AT-0174 is an orally active dual inhibitor of IDO1/TDO2 (tryptophan 2,3-dioxygenase-2) with IC50 values of 0.17 and 0.25 μM, respectively. AT-0174 has antitumor activity[1][2].

ATAD1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAD2 Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAD2B Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAD3A Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAD3B Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAD5 Human Pre-designed siRNA Set A contains three designed siRNAs for ATAD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATB-343 is a derivative of Indomethacin that releases H2S. H2S has cytoprotective and anti-inflammatory effects, inhibiting leukocyte adhesion to vascular endothelium and leukocyte migration to inflammatory sites. ATB-343 can be used to suppress respiratory infections[1][2].

ATCAY Human Pre-designed siRNA Set A contains three designed siRNAs for ATCAY gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATE1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF2 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF3 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF4 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF4-IN-1 (Compound 21) is an ATF4 inhibitor. ATF4-IN-1 inhibits ATF4 expression in Thapsigargin (HY-13433)-stimulated HEK-293T cells, with an IC50 value of 32.43 nM. ATF4-IN-1 is more active than ISRIB (HY-12495A). ATF4-IN-1 exhibits low cytotoxicity (IC50: 96 μM against HEK-293T cells). ATF4-IN-1 can be used for research of neurodegenerative diseases[1].

ATF4-IN-2 (Compound 29) is a ATF4 inhibitor with a IC50 value of 47.71 nM. ATF4-IN-2 can be used in the study of neurodegenerative diseases[1].

ATF5 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF6 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atf6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Atf6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atf6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Atf6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF6B Human Pre-designed siRNA Set A contains three designed siRNAs for ATF6B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF7 Human Pre-designed siRNA Set A contains three designed siRNAs for ATF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATF7IP Human Pre-designed siRNA Set A contains three designed siRNAs for ATF7IP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.